One of DMSG’s main tasks is to monitor the research field within myeloma and point attention to the new, important diagnostic methods and treatments which are under pivotal testing.

In connection with this task, DMSG prepares reports and mini MTVs regarding new medical treatments for the KRIS committee by Danish Regions. This work contributes in, on an evidence-based basis, ensuring quick implementation of new medical treatments, which benefits Danish patients.